
MICA is an AI decision support system focused on breast cancer diagnosis, helping radiologists analyze mammograms with advanced AI algorithms. It addresses challenges in detecting cancer in dense breasts, which affect 40% of women, by improving accuracy and reducing unnecessary biopsies by 40%. The system supports personalized treatment by diagnosing suspicious findings early, based on analysis of millions of image scans. MICA's products include DENISE, an AI algorithm validated at Sheba Hospital and approved by the Israeli Ministry of Health, M2C for reducing contrast agent dose, SHARK for rapid lesion detection, and MAMMOCOMPARE for mammogram comparison over time. The company operates with a SaaS business model, targeting hospitals and payers, and has a strong team with expertise in AI, medical imaging, and regulatory affairs. MICA aims to save lives, reduce healthcare costs, and improve diagnostic efficiency in breast cancer care.

MICA is an AI decision support system focused on breast cancer diagnosis, helping radiologists analyze mammograms with advanced AI algorithms. It addresses challenges in detecting cancer in dense breasts, which affect 40% of women, by improving accuracy and reducing unnecessary biopsies by 40%. The system supports personalized treatment by diagnosing suspicious findings early, based on analysis of millions of image scans. MICA's products include DENISE, an AI algorithm validated at Sheba Hospital and approved by the Israeli Ministry of Health, M2C for reducing contrast agent dose, SHARK for rapid lesion detection, and MAMMOCOMPARE for mammogram comparison over time. The company operates with a SaaS business model, targeting hospitals and payers, and has a strong team with expertise in AI, medical imaging, and regulatory affairs. MICA aims to save lives, reduce healthcare costs, and improve diagnostic efficiency in breast cancer care.